High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.
- Journal
- PubMed
In The Last Decade
doi.org/w82686166 →Countries where authors are citing High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.
This map shows the geographic impact of High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. more than expected).
Fields of papers citing High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.
This network shows the impact of High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers..
About High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.
This paper, published in 2000, received 673 indexed citations . Written by Stefan Walenta, Michael Lehrke, Kolbein Sundfør, Einar K. Rofstad and Wolfgang Mueller‐Klieser covering the research area of Cancer Research, Pulmonary and Respiratory Medicine and Oncology. It is primarily cited by scholars working on Cancer Research (424 citations), Molecular Biology (405 citations) and Oncology (120 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w82686166.